News Chart Lytix Biopharma

Equities

LYTIX

NO0010405780

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-05-24 am EDT			5-day change	1st Jan Change
6 ^NOK	+13.21%		+7.14%	+23.46%

Apr. 25	Lytix Biopharma Announces Approval of the Phase II Study in Early-Stage Skin Cancer Representing A Significant Commercial Opportunity	CI
Apr. 10	Lytix Biopharma to Raise Up to NOK55 Million via Share Offering	MT

25ad0c2844d375bd0c.MesRejkAA5P9Bg1idHx0DbhHpWNDyCaXAO-oDAb2qGA.WI54SlhXS-XINlRaMSkTX_YW_AoKrhW6S8LyNEuC0ChipUhKc2MxzJdteg~c1b0c237bc297a4c97139df2a0e6e07c